well [8, 9] . For example, in response to hypoxia, prodeath molecules such as cytochrome c or apoptosis-inducing factor (AIF) are released from mitochondria into the cytoplasm, where cell death cascades are activated [10] .
To better understand the molecular mechanisms underlying hypoxic cell death, we attempted to identify novel genes that mediate hypoxic cell death by subtraction suppression hybridization. Using this method, we identified the glioma tumor suppressor critical region 2 (GLTSCR2) gene, which was initially cloned as a novel gene that interacts with ICP22 and ICP0 of herpes simplex virus 1 [11] . The GLTSCR2 gene is localized in the putative 1.4-Mb tumor suppressive region of chromosome 19q, which is frequently altered in various human tumors, including diffuse gliomas [12] . More recently, GLTSCR2 has been reported to directly regulate the phosphorylation and stability of the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) [13] . While these reports suggest that GLTSCR2 may participate in tumor development, cell proliferation, or differentiation, the function of GLTSCR2 has yet to be characterized.
The purpose of this work was to investigate the role of GLTSCR2 in hypoxic cell death pathways. Our data categorize GLTSCR2 as a member of hypoxia-responsive pro-death genes that induce cell death when overexpressed.
Materials and Methods

Antibodies and Reagents
Anti-GLTSCR2 polyclonal antibody was produced by immunizing a rabbit with keyhole limpet hemocyanin-conjugated amino acid residues 178-193 (CTRAKPGPQDTVERPF) of human GLTSCR2. The antibody was purified from the immune serum by affinity chromatography. Anti-smac/DIABLO, anti-endonuclease G, anti-Omi/HtrA2, anti-Bax, anti-Bid, anti-BNip3, and anti-Noxa antibodies were purchased from Santa Cruz Biotechnology. Anti-Bad and anti-phospho-Bad antibodies were purchased from Cell Signaling Technology (Beverly, Mass., USA). Anti-AIF, anti-PARP, and anti-cytochrome c antibodies were purchased from Abcam (Cambridge, UK). All other reagents were obtained from Sigma-Aldrich (St. Louis, Mo., USA), unless otherwise specified.
Cell Culture, Hypoxic Condition, Cell Viability, and Cell Death Assay
The human A549 alveolar epithelial cell line was obtained from the American Type Culture Collection (Rockville, Md., USA) and cultured in RPMI 1640 medium (Gibco BRL, Carlsbad, Calif., USA) containing 10% fetal bovine serum under a 5% CO 2 atmosphere at 37 ° C. For hypoxic conditions, cells in medium degassed with 95% N 2 and 5% CO 2 were transferred to a hypoxic chamber (Ruskinn, Bridgend, UK) equipped with an air lock and continuously gassed with 2% O 2 and 5% CO 2 with the remainder as nitrogen. Cells stably expressing Bcl-2 (A549/Bcl-2) were created by transfecting A549 cells with Bcl-2 expressing plasmid (pcDNA-Bcl-2) followed by selection with G418. Apoptotic cells exhibiting altered nuclear morphology following 4 ,6 -diamidino-2-phenylindole (DAPI) staining were enumerated manually under a fluorescence microscope. Cell viability was determined using alamar blue [14] according to the manufacturer's protocol.
Subtractive Hybridization
Subtractive hybridization was performed with a PCR-Select cDNA Subtraction Kit (Clontech Laboratories, Mountain View, Calif., USA) according to the manufacturer's protocol, as described previously [15] .
Semiquantitative RT-Polymerase Chain Reaction Analysis
One microgram total RNA extracted from normoxia-or hypoxia-stimulated cells was converted to cDNA. The RT-polymerase chain reaction (PCR) exponential phase was determined as between 20 and 36 cycles to allow for semiquantitative comparisons. The PCR regimen for GLTSCR2 involved a 94 ° C, 5-min initial denaturation step, followed by 34 cycles of 94 ° C for 30 s, 54 ° C for 45 s, and 72 ° C for 45 s using a Gene Amp PCR system 9700 (PerkinElmer). The resulting PCR products were separated on 2% agarose gels and visualized by ethidium bromide staining. For semiquantitative evaluation, densitometric analysis (Bio-Rad Laboratories) was performed.
Plasmid Construction and Transient Transfection
DNAs encoding full length GLTSCR2 (accession No. NM_ 015710) or its deletion mutants were amplified by PCR from a human kidney cDNA library and cloned into pcDNA3.1/V5 (Invitrogen, Carlsbad, Calif., USA); this construct was then subcloned into a pEGFP vector (Clontech Laboratories). A549 cells (3 ! 10 5 /10-cm culture dish) were transiently transfected with each plasmid using Magnetofection according to the manufacturer's suggested protocol (Chemicell, Berlin, Germany).
Determination of Mitochondrial Membrane Potential
Transfected A549 cells were cultured under the indicated conditions, at which time MitoTracker Red CMXRos (Molecular Probes) was added to the medium at a final concentration of 400 n M . After 20 min of incubation, the cells were harvested and washed 3 times with phosphate-buffered saline (PBS). Fluorescence intensity was measured by flow cytometry (FC 500, Beckmann-Coulter).
Western Blotting and Immunocytochemistry
Western blotting was performed as described previously [16] . For immunocytochemistry, A549 cells were fixed with 4% paraformaldehyde in PBS and permeabilized with 0.1% Triton X-100. After blocking with 3% bovine serum albumin in PBS, the cells were incubated with primary antibody for 1.5 h at room temperature. Afterwards, the cells were stained with secondary antibody conjugated with fluorescein isothiocyanate or Texas Red and viewed after DAPI staining with a confocal microscope (META 510, Zeiss).
Suppression of Endogenous GLTSCR2 Expression by siRNA
Pairs of 19-nucleotide sense and antisense RNA oligomers were independently chemically synthesized and annealed by Bioneer (Daejeon, Korea). The oligonucleotides for GLTSCR2 were as follows: sense, 5 -GCA CAG GCU GCG GGU ACA G-3 and antisense, 5 -CUG UAC CCG CAG CCU GUG C-3 , which correspond to human GLTSCR2 coding nucleotides 1455-1475. The selected sequence (siA11) was subjected to a BLAST search to ensure that no other sequence in the human genome other than GLTSCR2 was targeted. The introduction of siRNA was carried out using Lipofectamine 2000 (Invitrogen) according to the manufacturer's suggested protocol.
Results
Identification of GLTSCR2 as a Hypoxia-Responsive Gene
Subtractive hybridization was performed to identify hypoxia-responsive genes in A549 lung epithelial cancer cells. Among the 15 putative hypoxia-regulated genes detected by subtractive hybridization, we identified the putative tumor suppressor gene GLTSCR2. To confirm the results of the subtractive hybridization, we performed semiquantitative RT-PCR and Western blot analysis using mRNA and cell lysates extracted from hypoxia-exposed A549 cells, respectively. As shown in figure 1 A and B, we found a time-dependent decrease of GLTSCR2 transcripts in response to hypoxia. Consistent with the RT-PCR results, protein levels were decreased to approximately 20% of the levels observed in normoxic cells after 48 h of hypoxia ( fig. 1 A, B) . Together, our data suggest that hypoxia resulted in transcriptional downregulation of GLTSCR2. Further, the hypoxia-induced downregulation of GLTSCR2 was observed in a variety of human and mouse cells including endothelial cells, neurons, and neuroblastoma cells (data not shown).
GLTSCR2 Sensitizes Cells to Apoptotic Cell Death Induced by Hypoxia
The data presented above indicated that hypoxia downregulated the transcription of GLTSCR2. Therefore, we wanted to know whether GLTSCR2 expression levels affected cellular susceptibility to hypoxia. To accomplish this, cells were transiently transfected with pEGFP-GLTSCR2 or a control vector for 12 h and then exposed to hypoxia (2% O 2 ) for an additional 24 h. After the hypoxic insult, cell viability was determined by alamar blue. The viability of empty-transfected cells was approximately 94% after exposure to 2% hypoxia for 24 h, Hypoxia induces transcriptional downregulation of GLTSCR2 expression. Cells were exposed to hypoxia (2% O 2 ) for the indicated times. A cDNA was synthesized from total RNA extracted from A549 cells exposed to hypoxia and subjected to RT-PCR analysis, or 30 g of cell lysate extracted from hypoxia-exposed cells were subjected to Western blot analysis using polyclonal anti-GLTSCR2 and anti-tubulin antibodies. Thirty-six and 26 cycles of amplification were performed for GLTSCR2 and GAPDH, respectively. The fold increases of GLTSCR2 expression (mean 8 SD) were determined using densitometry; the GLTSCR2 expression level at 48 h was arbitrarily defined as 1. B Representative RT-PCR (upper panel) and Western blot (lower panel) results.
but was decreased to approximately 36% in cells overexpressing GLTSCR2 ( fig. 2 A, B) . The respective expression level of GLTSCR2 was shown in figure 2 C. We subsequently suppressed GLTSCR2 expression by transfecting GLTSCR2 siRNA (siA11) and exposing cells to severe hypoxia (0.2% O 2 ) for 12 h. As shown in figure 2 D and E, suppression of GLTSCR2 expression rescued cells from severe hypoxic exposure. Downregulation of GLTSCR2 in siA11-transfected cells was confirmed by Western blots ( fig. 2 F) . These data suggest that GLTSCR2 sensitized cells to hypoxic injury.
Overexpression of GLTSCR2 Does Not Affect the Expression Level of Hypoxia-Responsive Proapoptotic Proteins
Many gene products, including proapoptotic Bcl-2 family proteins, play a role in sensitizing cells to hypoxia to mediate hypoxic cell death [17] . To elucidate whether the sensitization of cells to hypoxic injury by GLTSCR2 overexpression was mediated by induction of hypoxiaresponsive pro-death genes, we investigated the changes of these gene products. A549 cells were transfected with pEGFP-GLTSCR2 and expression of Bax, BNip3, Bid, and GLTSCR2 sensitizes cells to hypoxic injury. A A549 cells were transfected with pEGFP-empty or pEGFP-GLTSCR2 plasmid and then exposed to normoxia or 2% hypoxia 12 h after transfection. Cell viability was determined following 24 h of hypoxia. B Representative photomicrographs of A after DAPI staining. C Western blots for GLTSCR2 expression level of A . D Cells were transfected with siControl or siA11 for 48 h and then exposed to normoxia or severe hypoxia (0.2% O 2 ) for 12 h. Cell viability was determined using alamar blue. Results are presented as the mean 8 SD of three independent experiments. Data represent the percent ratio compared to untreated cells (UT) in normoxic condition. E Representative photomicrographs of D after DAPI staining. F Western blots for GLTSCR2 expression level of D .
Noxa was determined by Western blotting. As shown in figure 3 A, there was no significant upregulation of these pro-death proteins following 36 h of GLTSCR2 overexpression. Next, cells were made to overexpress Bax (pcDNA-Bax), Bid (pcDNA-Bid), BNip3 (pcDNABNip3), Noxa (pcDNA-Noxa), or GLTSCR2 (pcDNA-GLTSCR2) by transfecting the respective expression vector and then exposing the cells to hypoxia in the presence or absence of pan-caspase inhibitor (z-VAD). Following 24 h of exposure to hypoxia, cell viability was measured using alamar blue. As shown in figure 3 B, the pancaspase inhibitor suppressed hypoxic cell death in Bax-, Bid-, BNip3-, or Noxa-overexpressed cells while it did not affect hypoxic cell death in cells overexpressing GLTSCR2. Together, these data suggest that GLTSCR2 sensitized cells in a Bax-, Bid-, BNip3-, and Noxa-independent manner, and that cell death triggered by GLTSCR2 differs from that of other hypoxia-mediating pro-death proteins. GLTSCR2 is known to stabilize PTEN [13] . Therefore, to investigate the possible involvement of Bad phosphorylation, A549 cells were transfected with pcDNA-GLTSCR2 and Bad phosphorylation status was determined. As shown in figure 3 C, significant alteration in Bad phosphorylation status was not noted.
Sensitization to Hypoxia by GLTSCR2 Is Independent of Mitochondrial Death Cascades
Mitochondria play a central role in cell death induced by hypoxia. Disruption of the mitochondrial membrane potential (MMP) following the release of pro-death molecules into the cytoplasm is one of the early features of hypoxic cell death [18] . Therefore, we wanted to know whether sensitization to hypoxia by GLTSCR2 involved mitochondrial apoptotic cascades. To investigate this possibility, cells were transiently transfected with pEGFP-GLTSCR2 or empty vector and the MMP was measured in the GLTSCR2 overexpressing cells with Red CMXRos after 24 and 48 h posttransfection. As shown in figure 4 A, we did not detect a significant decrease of the MMP following 24 h of transfection, although a minimal decrease of MMP was noted after 48 h posttransfection. Next, the release of pro-death proteins from mitochondria, including cytochrome c, AIF, endonuclease G, Omi/ HtrA2, and smac/DIABLO, was determined using immunofluorescence staining. Consistent with the insignificant alteration in MMP, a release of pro-death proteins from mitochondria was not noted, further confirming that GLTSCR2-mediated apoptosis was independent of the mitochondrial apoptotic cascade ( fig. 4 B) .
Effect of Bcl-2 Overexpression on GLTSCR2-Induced Cell Death
Bcl-2 regulates various types of cell death pathways by stabilizing mitochondrial membrane permeability [19] . To confirm that GLTSCR2-induced apoptosis does not involve mitochondrial perturbation, we examined whether Bcl-2 could inhibit GLTSCR2-sensitized hypoxic cell death. Cells stably expressing Bcl-2 (A549/Bcl-2) and control cells (A549/Empty) ( fig. 5 A) were transfected with pEGFP-GLTSCR2 and exposed to 2% hypoxia after 12 h of transfection. The cell death rate was measured after hyp- oxic exposure of the indicated time intervals by alamar blue. As depicted in figure 5 B, Bcl-2 overexpression did not affect the cell death induced by GLTSCR2 overexpression, indicating that mitochondrial perturbation is not primarily responsible for GLTSCR2-induced cell death.
Discussion
Hypoxia/ischemia is the most common cause of cell injuries and participates in numerous pathological processes such as ischemic stroke, myocardial infarction and chronic degenerative disorders [20] . When exposed to hypoxia, cells transactivate a variety of genes to adapt to altered metabolic demands or to remove irreversibly damaged cells [21] . Among the transcription factors that respond to hypoxia, HIF-1 ␣ and p53 appear to be key modulators because they transactivate numerous genes responsible for increased oxygen delivery, cell cycle arrest, or apoptosis [22, 23] . Although survival genes and the molecular pathways that protect against cell death in response to hypoxia are relatively well documented, death-promoting genes induced by hypoxia are less clarified. Here we report the identification of GLTSCR2, a new hypoxia-responding gene that sensitizes cells to hypoxic injury.
Our data obtained from semiquantitative RT-PCR and cell viability assays demonstrated that overexpression of GLTSCR2 sensitized cells to hypoxic injury. However, GLTSCR2 seems to be different from other hypoxia-responding proteins such as BNip3 [3] , Noxa [15] , and HGTD-P [24] in both their regulation of expression patterns and mechanism of action. First, while a majority of pro-death genes are upregulated by hypoxic stimulation, GLTSCR2 expression was suppressed by 2% hypoxia. It is not clear what transcriptional factor(s) induced by hypoxia are responsible for the transcriptional inactivation of the GLTSCR2 promoter. Nevertheless, it might be explained as a cellular adaptation process which protects cells from hypoxic stress. Second, the cell death pathway sensitized by GLTSCR2 was independent of mitochondrial death cascades. Hypoxia-responding pro-death genes, e.g., Bax and Bid [25, 26] , perturb mitochondria and result in a loss of MMP and subsequent release of death molecules from the intermembranous space. In the case of GLTSCR2, an activation of such mitochondrial death cascades was not observed. Specifically, (1) membrane potentials were maintained, (2) death molecules from mitochondria were not released, and (3) caspase was not activated. Although these results do not completely rule out the possible involvement of hypoxia-responsive pro-death proteins such as p53 and HIF-1 ␣ , they, together with the insignificant alteration in expression of their downstream proteins, strongly imply that GLTSCR2 triggered cell death pathways independent of these proteins. One putative mechanism for GLTSCR2-induced cell death may include PTEN-regulated signaling cascades. However, it is unlikely that the phosphorylation status of Bad by PTEN-Akt cascade is critical for GLTSCR2-induced cell death ( fig. 3 A) . Further studies to elucidate the precise molecular pathway of GLTSCR2 in association with PTEN are ongoing.
Because hypoxia is involved in numerous disease processes such as ischemic stroke, myocardial infarction and chronic degenerative disorders, hypoxia-induced cell death genes are important targets for the development of drugs or other treatment modalities. Overall, the data presented here led us to conclude that GLTSCR2 sensitizes cells to hypoxic injury independent of mitochondria. It may be interesting to study the potential biological significance of GLTSCR2 in transgenic and knockout mice.
